{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:01:03Z","timestamp":1773792063632,"version":"3.50.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,5,30]],"date-time":"2014-05-30T00:00:00Z","timestamp":1401408000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Tumor Biol."],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s13277-014-2141-4","type":"journal-article","created":{"date-parts":[[2014,5,29]],"date-time":"2014-05-29T04:14:34Z","timestamp":1401336874000},"page":"8743-8747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Expression of MLH1 and MSH2 in urothelial carcinoma of the renal pelvis"],"prefix":"10.1007","volume":"35","author":[{"given":"Laleh","family":"Ehsani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adeboye O.","family":"Osunkoya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,5,30]]},"reference":[{"key":"2141_CR1","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0022-5347(17)41291-2","volume":"141","author":"J Oldbring","year":"1989","unstructured":"Oldbring J, Glifberg I, Mikulowski P, et al. Carcinoma of the renal pelvis and ureter following bladder carcinoma: frequency, risk factors and clinicopathological findings. J Urol. 1989;141:1311\u20133.","journal-title":"J Urol"},{"key":"2141_CR2","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S0090-4295(98)00295-7","volume":"52","author":"MC Hall","year":"1998","unstructured":"Hall MC, Womack S, Sagalowsky AI, et al. Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients. Urology. 1998;52:594\u2013601.","journal-title":"Urology"},{"key":"2141_CR3","first-page":"3230","volume":"61","author":"LA Loeb","year":"2001","unstructured":"Loeb LA. A mutator phenotype in cancer. Cancer Res. 2001;61:3230\u20139.","journal-title":"Cancer Res"},{"key":"2141_CR4","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/25292","volume":"396","author":"C Lengauer","year":"1998","unstructured":"Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature. 1998;396:643\u20139.","journal-title":"Nature"},{"key":"2141_CR5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","volume":"348","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, de la Chapelle A. Hereditary colorectal cancer. N Engl J Med. 2003;348:919\u201332.","journal-title":"N Engl J Med"},{"issue":"7","key":"2141_CR6","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1136\/jmg.2010.076992","volume":"47","author":"RS Post van der","year":"2010","unstructured":"van der Post RS, Kiemeney LA, Ligtenberg MJ, et al. Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. J Med Genet. 2010;47(7):464\u201370.","journal-title":"J Med Genet"},{"key":"2141_CR7","doi-asserted-by":"crossref","first-page":"430e3","DOI":"10.1002\/ijc.2910640613","volume":"64","author":"M Aarnio","year":"1995","unstructured":"Aarnio M, Mecklin JP, Aaltonen LA, Nystrom-Lahti M, Jarvinen HJ. Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer. 1995;64:430e3.","journal-title":"Int J Cancer"},{"key":"2141_CR8","doi-asserted-by":"crossref","first-page":"4074e80","DOI":"10.1200\/JCO.2001.19.20.4074","volume":"19","author":"HF Vasen","year":"2001","unstructured":"Vasen HF, Stormorken A, Menko FH, Nagengast FM, Kleibeuker JH, Griffioen G, et al. MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol. 2001;19:4074e80.","journal-title":"J Clin Oncol"},{"key":"2141_CR9","doi-asserted-by":"crossref","first-page":"105e10","DOI":"10.1093\/hmg\/6.1.105","volume":"6","author":"MG Dunlop","year":"1997","unstructured":"Dunlop MG, Farrington SM, Carothers AD, Wyllie AH, Sharp L, Burn J, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet. 1997;6:105e10.","journal-title":"Hum Mol Genet"},{"key":"2141_CR10","doi-asserted-by":"crossref","first-page":"17e25","DOI":"10.1053\/j.gastro.2004.03.068","volume":"127","author":"YM Hendriks","year":"2004","unstructured":"Hendriks YM, Wagner A, Morreau H, Menko F, Stormorken A, et al. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance. Gastroenterology. 2004;127:17e25.","journal-title":"Gastroenterology"},{"key":"2141_CR11","doi-asserted-by":"crossref","first-page":"491e6","DOI":"10.1136\/jmg.2004.024299","volume":"42","author":"F Quehenberger","year":"2005","unstructured":"Quehenberger F, Vasen HF, van Houwelingen HC. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment. J Med Genet. 2005;42:491e6.","journal-title":"J Med Genet"},{"key":"2141_CR12","doi-asserted-by":"crossref","first-page":"466e70","DOI":"10.1016\/S0022-5347(01)62926-4","volume":"160","author":"RH Sijmons","year":"1998","unstructured":"Sijmons RH, Kiemeney LA, Witjes JA, Vasen HF. Urinary tract cancer and hereditary nonpolyposis colorectal cancer: risks and screening options. J Urol. 1998;160:466e70.","journal-title":"J Urol"},{"key":"2141_CR13","doi-asserted-by":"crossref","first-page":"664e70","DOI":"10.1111\/j.1572-0241.2003.07329.x","volume":"98","author":"HT Lynch","year":"2003","unstructured":"Lynch HT, Taylor RJ, Lynch JF, et al. Multiple primary cancer, including transitional cell carcinoma of the upper uroepithelial tract in a multigeneration HNPCC family: molecular genetic, diagnostic, and management implications. Am J Gastroenterol. 2003;98:664e70.","journal-title":"Am J Gastroenterol"},{"key":"2141_CR14","doi-asserted-by":"crossref","first-page":"1020e7","DOI":"10.1053\/gast.1996.v110.pm8612988","volume":"110","author":"HF Vasen","year":"1996","unstructured":"Vasen HF, Wijnen JT, Menko FH, et al. Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis. Gastroenterology. 1996;110:1020e7.","journal-title":"Gastroenterology"},{"key":"2141_CR15","doi-asserted-by":"crossref","first-page":"677e85","DOI":"10.1002\/1097-0142(19930201)71:3<677::AID-CNCR2820710305>3.0.CO;2-#","volume":"71","author":"P Watson","year":"1993","unstructured":"Watson P, Lynch HT. Extracolonic cancer in hereditary nonpolyposis colorectal cancer. Cancer. 1993;71:677e85.","journal-title":"Cancer"},{"key":"2141_CR16","doi-asserted-by":"crossref","first-page":"193e201","DOI":"10.1093\/jnci\/djp473","volume":"102","author":"L Baglietto","year":"2010","unstructured":"Baglietto L, Lindor NM, Dowty JG, et al. Risks of Lynch syndrome cancers for MSH6 mutation carriers. J Natl Cancer Inst. 2010;102:193e201.","journal-title":"J Natl Cancer Inst"},{"key":"2141_CR17","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/ng0195-48","volume":"9","author":"B Liu","year":"1995","unstructured":"Liu B, Nicolaides NC, Markowitz S, et al. Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability. Nat Genet. 1995;9:48\u201355.","journal-title":"Nat Genet"},{"key":"2141_CR18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1056\/NEJM200001133420201","volume":"342","author":"R Gryfe","year":"2000","unstructured":"Gryfe R, Kim H, Hsieh ET, et al. Tumor microsatellite instability and clinical outcome in young patients with colorectal cancer. N Engl J Med. 2000;342:69\u201377.","journal-title":"N Engl J Med"},{"key":"2141_CR19","doi-asserted-by":"crossref","first-page":"19645","DOI":"10.1074\/jbc.271.33.19645","volume":"271","author":"JT Drummond","year":"1996","unstructured":"Drummond JT, Anthoney A, Brown R, Modrich P. Cisplatin and adriamysin resistance are associated with MutLA and mismatch repair deficiency in an ovarian tumour cell line. J Biol Chem. 1996;271:19645\u20138.","journal-title":"J Biol Chem"},{"key":"2141_CR20","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1126\/science.8484122","volume":"260","author":"SN Thibodeau","year":"1993","unstructured":"Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816\u20139.","journal-title":"Science"},{"key":"2141_CR21","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/(SICI)1097-0142(19980515)82:10<1808::AID-CNCR2>3.0.CO;2-J","volume":"82","author":"II Arzimanoglou","year":"1998","unstructured":"Arzimanoglou II, Gilbert F, Barber HR. Microsatellite instability in human solid tumors. Cancer. 1998;82:1808\u201320.","journal-title":"Cancer"},{"key":"2141_CR22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0046-8177(00)80250-6","volume":"31","author":"A Staebler","year":"2000","unstructured":"Staebler A, Lax SF, Ellenson LH. Altered expression of hMLH1 and hMSH2 protein in endometrial carcinomas with microsatellite instability. Hum Pathol. 2000;31:354\u20138.","journal-title":"Hum Pathol"},{"issue":"15","key":"2141_CR23","first-page":"3455","volume":"58","author":"JM Cunningham","year":"1998","unstructured":"Cunningham JM, Cunningham JM, Christensen ER, et al. Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability. Cancer Res. 1998;58(15):3455\u201360.","journal-title":"Cancer Res"},{"key":"2141_CR24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1097\/01.MP.0000024263.25043.0C","volume":"15","author":"H Blaszyk","year":"2002","unstructured":"Blaszyk H, Wang L, Dietmaier W, et al. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis. Mod Pathol. 2002;15:790\u20137.","journal-title":"Mod Pathol"},{"issue":"3","key":"2141_CR25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1053\/hupa.2003.22","volume":"34","author":"A Hartmann","year":"2003","unstructured":"Hartmann A, Dietmaier W. Hofst\u00e4dter F,\u2009et al Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hum Pathol. 2003;34(3):222\u20137.","journal-title":"Hum Pathol"},{"key":"2141_CR26","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S0090-4295(98)00225-8","volume":"52","author":"AN Chiura","year":"1998","unstructured":"Chiura AN, Wirtschafter A, Bagley DH. Upper urinary tract inverted papillomas. Urology. 1998;52:514\u20136.","journal-title":"Urology"},{"key":"2141_CR27","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1002\/(SICI)1097-0142(19970601)79:11<2178::AID-CNCR16>3.0.CO;2-T","volume":"79","author":"A Rey","year":"1997","unstructured":"Rey A, Lara PC, Redondo E, et al. Overexpression of p53 in transitional cell carcinoma of the renal pelvis and ureter: relation to tumor proliferation and survival. Cancer. 1997;79:2178\u201385.","journal-title":"Cancer"},{"key":"2141_CR28","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0304-3835(98)00055-X","volume":"128","author":"VN Bilim","year":"1998","unstructured":"Bilim VN, Tomita Y, Kawasaki T, et al. Variable Bcl-2 phenotype in benign and malignant lesions of urothelium. Cancer Lett. 1998;128:87\u201392.","journal-title":"Cancer Lett"},{"issue":"23","key":"2141_CR29","first-page":"6796","volume":"62","author":"A Hartmann","year":"2002","unstructured":"Hartmann A, Zanardo L, Bocker-Edmonston T, et al. Frequent microsatellite instability in sporadic tumors of the upper urinary tract. Cancer Res. 2002;62(23):6796\u2013802.","journal-title":"Cancer Res"},{"issue":"6","key":"2141_CR30","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1016\/j.urology.2005.01.019","volume":"65","author":"M Roupr\u00eat","year":"2005","unstructured":"Roupr\u00eat M, Fromont G, Azzouzi AR, et al. Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma. Urology. 2005;65(6):1233\u20137.","journal-title":"Urology"},{"issue":"4","key":"2141_CR31","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1464-410X.2005.05671.x","volume":"96","author":"M Roupr\u00eat","year":"2005","unstructured":"Roupr\u00eat M, Azzouzi AR, Cussenot O. Microsatellite instability and transitional cell Carcinoma of the upper urinary tract. BJU Int. 2005;96(4):489\u201392.","journal-title":"BJU Int"},{"key":"2141_CR32","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1080\/0031302021000035965-2","volume":"34","author":"A Ruszkiewicz","year":"2002","unstructured":"Ruszkiewicz A, Bennett G, Moore J, et al. Correlation of mismatch repair genes immunohistochemistry and microsatellite instability status in HNPCC-associated tumours. Pathol- ogy. 2002;34:541\u20137.","journal-title":"Pathol- ogy"},{"key":"2141_CR33","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1200\/JCO.20.4.1043","volume":"20","author":"NM Lindor","year":"2002","unstructured":"Lindor NM, Burgart LJ, Leontovich O, et al. Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol. 2002;20:1043\u20138.","journal-title":"J Clin Oncol"},{"key":"2141_CR34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/gut.2003.019190","volume":"53","author":"Y Parc","year":"2004","unstructured":"Parc Y, Gueroult S, Mourra N, et al. Prognostic significance of microsatellite instability determined by immunohistochemical staining of MSH2 and MLH1 in sporadic T3N0M0 colon cancer. Gut. 2004;53:371\u20135.","journal-title":"Gut"},{"key":"2141_CR35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1056\/NEJMoa022289","volume":"349","author":"CM Ribic","year":"2003","unstructured":"Ribic CM, Sargent DJ, Moore MJ, et al. Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med. 2003;349:247\u201357.","journal-title":"N Engl J Med"}],"container-title":["Tumor Biology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2141-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13277-014-2141-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13277-014-2141-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T03:27:28Z","timestamp":1565494048000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13277-014-2141-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,30]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["2141"],"URL":"https:\/\/doi.org\/10.1007\/s13277-014-2141-4","relation":{},"ISSN":["1010-4283","1423-0380"],"issn-type":[{"value":"1010-4283","type":"print"},{"value":"1423-0380","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,30]]}}}